Gene · 2091
Papers2,899
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,899
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of Human Nucleolus Upon Guest Viral-Life, Focusing in COVID-19 Infection: A Mini- Review. | Iran J Pathol | 2022 | 35096082 | PubTator, text mining | PubMed |
| Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports. | J Med Case Rep | 2022 | 35094715 | PubTator, text mining | PubMed |
| Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis. | Hum Mol Genet | 2022 | 35094092 | PubTator, text mining | PubMed |
| Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancer. | Oncogene | 2022 | 35094010 | PubTator, text mining | PubMed |
Tumor Susceptibility Gene 101 (TSG101) Contributes to Virion Formation of Porcine Reproductive and Respiratory Syndrome Virus via Interaction with the Nucleocapsid (N) Protein along with the Early Secretory Pathway. | J Virol | 2022 | 35080428 | PubTator, text mining | PubMed |
| Selective translation of epigenetic modifiers affects the temporal pattern and differentiation of neural stem cells. | Nat Commun | 2022 | 35078993 | PubTator, text mining | PubMed |
| A high-throughput assay for directly monitoring nucleolar rRNA biogenesis. | Open Biol | 2022 | 35078352 | PubTator, text mining | PubMed |
| Insights into the specificity for the interaction of the promiscuous SARS-CoV-2 nucleocapsid protein N-terminal domain with deoxyribonucleic acids. | Int J Biol Macromol | 2022 | 35077748 | PubTator, text mining | PubMed |
| Factors associated with COVID-19 pandemic induced post-traumatic stress symptoms among adults living with and without HIV in Nigeria: a cross-sectional study. | BMC Psychiatry | 2022 | 35062920 | PubTator, text mining | PubMed |
| The Role of Nucleophosmin 1 (NPM1) Mutation in the Diagnosis and Management of Myeloid Neoplasms. | Life (Basel) | 2022 | 35054502 | PubTator, text mining | PubMed |
| SCF Ligases and Their Functions in Oogenesis and Embryogenesis-Summary of the Most Important Findings throughout the Animal Kingdom. | Cells | 2022 | 35053348 | PubTator, text mining | PubMed |
| The Effect of Anti-Scl-70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis. | ACR Open Rheumatol | 2022 | 35048554 | PubTator, text mining | PubMed |
| Redesigning therapies for pantothenate kinase-associated neurodegeneration. | J Biol Chem | 2022 | 35041826 | PubTator, text mining | PubMed |
| Systematic mapping of rRNA 2'-O methylation during frog development and involvement of the methyltransferase Fibrillarin in eye and craniofacial development in Xenopus laevis. | PLoS Genet | 2022 | 35041640 | PubTator, text mining | PubMed |
| Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer. | J Exp Clin Cancer Res | 2022 | 35039048 | PubTator, text mining | PubMed |
| Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application. | J Transl Autoimmun | 2022 | 35028553 | PubTator, text mining | PubMed |
| De novo mutations identified by whole-genome sequencing implicate chromatin modifications in obsessive-compulsive disorder. | Sci Adv | 2022 | 35020433 | PubTator, text mining | PubMed |
| COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature. | J Transl Autoimmun | 2022 | 35013724 | PubTator, text mining | PubMed |
| Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance. | Nat Commun | 2022 | 35013311 | PubTator, text mining | PubMed |
| EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation. | Nat Commun | 2022 | 35013218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2091/papers?page=35